Novacyt SA (NCYT) Stock Price & News

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia

About Novacyt SA

CEODavid Allmond

Employees228

Founded2006 оны 7-р сарын 3

Headquarters-

Sector-

Websitenovacyt.com

All values in GBP	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар
Revenue	5.12 сая	5.12 сая	5.78 сая	5.78 сая
Cost of goods sold	2.61 сая	2.61 сая	2.56 сая	2.56 сая
Cost of revenue	2.61 сая	2.61 сая	2.56 сая	2.56 сая
Research and development expenses	1.03 сая	1.03 сая	1.06 сая	1.06 сая
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.69 сая	4.69 сая	4.65 сая	4.65 сая
Operating expense	5.54 сая	5.54 сая	5.66 сая	5.66 сая
Total operating expenses	8.16 сая	8.16 сая	8.22 сая	8.22 сая
Operating income	-3.04 сая	-3.04 сая	-2.44 сая	-2.44 сая
Other non operating income	-23.00 мян	-23.00 мян	-47.50 мян	-47.50 мян
EBT including unusual items	-10.16 сая	-10.16 сая	-2.91 сая	-2.91 сая
EBT excluding unusual items	-2.52 сая	-2.52 сая	-2.80 сая	-2.80 сая
Income tax expense	-1.81 сая	-1.81 сая	-49.50 мян	-49.50 мян
Effective tax rate	17.85%	17.85%	1.70%	1.70%
Other operating expenses	-180.50 мян	-180.50 мян	-44.00 мян	-44.00 мян
Net income	-8.27 сая	-8.27 сая	-2.90 сая	-2.90 сая
Net profit margin	-161.60%	-161.60%	-50.13%	-50.13%
Earnings per share	-	-	-	-
Interest and investment income	149.00 мян	149.00 мян	63.00 мян	63.00 мян
Interest expense	-146.00 мян	-146.00 мян	-139.00 мян	-139.00 мян
Net interest expenses	3.00 мян	3.00 мян	-76.00 мян	-76.00 мян
Depreciation and amortization charges	-	-	-	-
EBITDA	3.46 сая	3.46 сая	-1.88 сая	-1.88 сая
Gain or loss from assets sale	-3.00 мян	-3.00 мян	8.00 мян	8.00 мян

Ask anything